Melanoma

Fast Facts | Key Research | More Resources

 

Melanoma: Fast Facts

Find a Clinical Trial

Read more about melanoma prevention, symptoms and treatment options at the Seattle Cancer Care Alliance. »

[ Back to Top ]
 

Melanoma: Some of Our Key Research

Supercharging the body's cancer-fighting powers

Some two years after the 52-year-old Oregon man received an infusion of 5 billion copies of his own CD4+ T-cells, a type of white blood cell that attacks a specific or foreign protein associated with his cancer, he continued to be melanoma-free.

Because Yee's findings represented only one patient, he plans to do broader studies in hopes of confirming the findings. If the technique—known as adoptive T-cell therapy—shows promise in a larger set of patients, Yee predicts this therapy could be used for the 25 percent of all late-stage melanoma patients who share the same key immune-system traits as the successful test patient. Learn more about Yee's melanoma-therapy study. »


[ Back to Top ]
 

Melanoma: More Resources

[ Back to Top ]

Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.

CenterNetCheck E-mail